MENU
+Compare
CELC
Stock ticker: NASDAQ
AS OF
May 23 closing price
Price
$10.44
Change
-$0.31 (-2.88%)
Capitalization
395.32M

CELC Celcuity Forecast, Technical & Fundamental Analysis

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology... Show more

CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CELC with price predictions
May 23, 2025

CELC sees its Stochastic Oscillator recovers from oversold territory

On May 09, 2025, the Stochastic Oscillator for CELC moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on CELC as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CELC moved above its 50-day moving average on May 12, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CELC crossed bullishly above the 50-day moving average on April 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CELC advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 177 cases where CELC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CELC turned negative on May 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CELC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CELC broke above its upper Bollinger Band on April 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.562) is normal, around the industry mean (16.345). P/E Ratio (0.000) is within average values for comparable stocks, (59.117). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.182). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (279.466).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CELC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CELC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CELC is expected to report earnings to rise 3.69% to -89 cents per share on August 07

Celcuity CELC Stock Earnings Reports
Q2'25
Est.
$-0.89
Q1'25
Missed
by $0.14
Q4'24
Missed
by $0.04
Q3'24
Est.
$-0.65
Q2'24
Beat
by $0.10
The last earnings report on May 14 showed earnings per share of -86 cents, missing the estimate of -72 cents. With 144.76K shares outstanding, the current market capitalization sits at 395.32M.
A.I. Advisor
published General Information

General Information

a biotechnology company develops novel diagnostic tests

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
16305 36th Avenue North
Phone
+1 763 392-0767
Employees
55
Web
https://www.celcuity.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCFEX16.240.14
+0.87%
WCM Focused Emerging Mkts Ex Chn Inv
VVIIX12.420.02
+0.16%
VOYA VACS Index Series I Portfolio
JFEIX38.57-0.04
-0.10%
JPMorgan Europe Dynamic L
FAAIX28.12-0.03
-0.11%
Fidelity Advisor Asset Manager 70% I
TVRIX17.17-0.06
-0.35%
NAA Allocation Fund Institutional

CELC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with ATXS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-2.88%
ATXS - CELC
44%
Loosely correlated
N/A
CLDX - CELC
44%
Loosely correlated
+2.01%
ABOS - CELC
44%
Loosely correlated
-1.92%
CCCC - CELC
43%
Loosely correlated
+1.47%
BEAM - CELC
42%
Loosely correlated
-2.26%
More